Stockscreener 앱 받기
8.36
0.97%
0.08
Regenxbio Inc (RGNX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
2.03%
30.34
|
29.73 | 21.36 | 89.01 | 21.21 |
Operating Expenses
|
7.10%
87.97
|
82.14 | 84.64 | 76.89 | 66.26 |
| Benefits Costs and Expenses |
18.68%
97.49
|
82.14 | 84.64 | 82.93 | 72.40 |
| Costs And Expenses |
7.10%
87.97
|
82.14 | 84.64 | 76.89 | 72.58 |
| Depreciation and Amortization |
0.44%
3.869
|
3.886 | 3.905 | 3.955 | 4.023 |
| Operating Income/Loss |
9.97%
-57.64
|
-52.41 | -63.28 | 12.13 | -51.37 |
| Nonoperating Income/Loss |
0.18%
-9.513
|
-9.53 | -7.593 | -6.044 | 0.182 |
| Income/Loss From Continuing Operations Before Tax |
28.12%
-67.15
|
-52.41 | -63.28 | 6.083 | -51.19 |
| Income/Loss From Continuing Operations After Tax |
8.41%
-67.15
|
-61.94 | -70.87 | 6.083 | -51.19 |
|
Net Income/Loss
|
8.41%
-67.15
|
-61.94 | -70.87 | 6.083 | -51.19 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.88%
0.06
|
51.69 | 51.48 | 51.36 | 0.458 |
| Diluted Average Shares |
99.88%
0.06
|
51.69 | 51.48 | 51.43 | 0.458 |
| Basic Earnings Per Share |
8.33%
-1.30
|
-1.20 | -1.38 | 0.12 | -1.00 |
| Diluted Earnings Per Share |
8.33%
-1.30
|
-1.20 | -1.38 | 0.12 | -1.00 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.20%
0.06%
자본화:
|
볼륨(24시간):